Alitretinoin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Alitretinoin. Educational only — not medical advice.
Labeled uses
1.1 Kaposi’s Sarcoma PANRETIN GEL is indicated for topical treatment of cutaneous lesions in adults with AIDS related Kaposi’s sarcoma (KS). Limitations of Use: PANRETIN GEL is not indicated when systemic anti-KS therapy is required (including more than 10 new KS lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary KS, or symptomatic visceral involvement) [see Clinical Studies (14.1 )] .
Source: FDA labeling via NIH DailyMed (set 49c16717…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.